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ABSTRACT 
Haemodialysis patients have acquired immunity dis-
turbances, co-morbidities and a vascular access, factors 
predisposing them to infection and bacteraemia. Clostrid-
ium perfringens is an anaerobic bacterium potentially 
causing severe infections, including rarely septic arthritis. 
We report the first case of Clostridium perfringens septic 
arthritis in a haemodialysis patient and suggest a haema-
togenous spread. After rapid joint lavage combined with 
appropriate anti-microbial therapy, the patient recov-
ered.
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INTRODUCTION
Haemodialysis (Hd) patients have acquired immunity 
disturbances, co-morbidities and a vascular access, these 
factors predisposing them to infection and bacteraemia 
(1-3). the type of vascular access is the most important pre-
dictor of infection, with native arteriovenous (AV) fistulas 
being safer than AV grafts [relative risk (rr) of bloodstream 
infection of 1.47 when compared to AV fistulas], and cuffed 
central venous catheters (rr 8.49) (4). most bacteraemia in 
Hd patients are caused by gram-positive pathogens, pre-
dominantly staphylococcus aureus and staphylococcus epi-
dermidis, and are frequently associated with metastatic 
complications (mainly endocarditis and osteoarticular infec-
tions) (3). 
Clostridium perfringens is an anaerobic bacterium, poten-
tially causing severe infections, such as gas gangrenes and 
food borne toxin-mediated infection, and rarely septic arthri-
tis (5). We report the first case of Clostridium perfringens septic 
arthritis in a haemodialysis patient.
CASE REPORT
A 36-year-old Caucasian man presented to our Hd unit in 
november 2009 with hyperglycaemia (479 mg/dl), fatigue 
and persistent right hip and calf pain since 2 days. He had 
been examined in the emergency unit the day before, and 
conventional radiography of the hip showed no fracture or 
increased peri-articular soft-tissue density. trochanteric tend-
initis was diagnosed and the patient was sent home with 
analgesics. His medical history included type1-diabetes mel-
litus with advanced retinopathy leading to blindness and dia-
betic nephropathy, chronic hepatitis C and alcohol and past 
drug (cocaine and heroin) use. HiV testing was negative in 
July 2009. He was on Hd for the last 3 years via a right internal 
jugular tunnelled catheter and was receiving acenocoumarol 
(anti-vitamin K, a derivative of coumarin) since 2007 for a 
superior vena cava thrombosis. He had a low socioeconomic 
status and had been repeatedly hospitalised for severe hypo-
glycaemia. His regular medications included aspirin, insulin, 
losartan, omeprazole, sevelamer, amlodipine and calcium car-
bonate. 
At the Hd unit, the patient complained of chills. there was 
no diarrhoea or abdominal pain. Clinical examination showed 
tachycardia (120 bpm), low blood pressure (90/50 mmHg), 
body temperature of 37°C, right hip pain with impaired 
mobility and painful decreased range of movement. the dial-
ysis catheter exit site was clean and there was no sign of tun-
nel infection. Blood tests showed a C-reactive protein plasma 
level of 8 mg/dl (nl < 1 mg/dl) and a white blood cell count 
of 13.000/mm3. A bloodstream infection was suspected, 
blood cultures were obtained and the patient was treated 
with vancomycin because of a recent staphylococcus epider-
midis exit site infection. on the following day, blood cultures 
grew a gram-positive bacillus. An arthro-Ct-scan of the right 
hip was performed and diagnostic arthrocentesis yielded 
1 ml of cloudy fluid, suggesting septic hip arthritis. right hip 
arthrotomy and lavage were immediately performed. Blood 
(1/1 set), hip fluid (3/5 sets) and biopsy of the capsule of the 
hip joint (1/1 set) cultures all grew Clostridium perfringens. 
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in most published cases of Clostridium species arthritis, 
arthrotomy or arthroscopy was necessary (5). 
Although metastatic septic arthritis secondary to staphy-
lococcus aureus bacteraemia in Hd patients is not uncommon, 
our case is the first report of Clostridium perfringens septic 
arthritis in a Hd patient. no traumatic wound or skin defect 
was identified and we speculate that the bacteraemia was 
catheter-related. We cannot however exclude, in this past iv 
drug user, a transmission through a contaminated iv drug nee-
dle. the tunnelled catheter was not removed as the patient 
rapidly improved and subsequent blood cultures were nega-
tive. the patient had no abdominal complaint and refused 
colonoscopic investigation. our patient was treated classically, 
with iv penicillin and emergency arthrotomy and lavage. 
CONCLUSION
We report the first case of Clostridium perfringens septic 
arthritis in a Hd patient and suggest a haematogenous 
spread via the tunnelled catheter. our report is original in 
2 ways: septic arthritis in Hd patients is usually secondary to 
vascular access-related staphylococcus species bacteraemia. 
secondly, septic arthritis due to Clostridium perfringens is very 
rare and mostly secondary to a traumatic, penetrating injury, 
and only rarely to a haematogenous spread. A prompt 
diagnosis and medico-surgical treatment is important: our 
patient recovered completely. 
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Vancomycin was switched to intravenous (iv) penicillin 
(1.6 million iu four times a day) and iv clindamycin (600 mg 
three times a day). Hip pain rapidly decreased and the patient 
recovered normal hip mobility 6 weeks after the initiation of 
antibiotics. After 2 weeks of iV antibiotics, the patient insisted 
on being discharged. the therapy was thus shifted to oral 
amoxicillin (500 mg three times a day ) and clindamycin 
(300 mg four times a day) after 2 weeks, and administered for 
a total of 6 weeks. Although catheter-related Clostridium per-
fringens bacteraemia was suspected, a colonoscopy was pro-
posed to search for a digestive origin to the bacteraemia, but 
the patient refused. the patient presented no skin defect on 
inspection, and had no contact with pets or other animals. 
DISCUSSION
Blood stream infection is a leading cause of morbidity and 
mortality in dialysis patients (2, 3, 6). After stratification for 
age, the risk of fatal sepsis is approximately 100-fold higher in 
dialysed patients than in the general population (6). the vas-
cular access is implicated in up to 89% of bacteraemia in Hd 
patients (3). patients with a central venous catheter have a 
greater risk of bacteraemia than those with a native AV fistula 
(2, 4). A retrospective analysis of Hd patients in three centres 
in the united Kingdom showed a < 0.5% yearly incidence of 
microbiologically proven septic arthritis (7). this study identi-
fied 15 cases of septic arthritis over a 6-year period, with the 
knee joint affected in 11/15 cases. patients had a mean age of 
67 years and 47% were diabetics. synovial fluid and blood cul-
tures grew staphylococcus species in 13/15 cases and strepto-
coccus species in the other 2 cases. the source of sepsis was 
the vascular access in 12/15 cases. one patient died of sepsis, 
and two developed chronic osteomyelitis. 
septic arthritis is rarely caused by anaerobic bacteria, and 
less than 40 cases due to Clostridium species have been 
reported in the general population (5, 8). Clostridium perfrin-
gens is present in contaminated food and in soil, and causes 
severe infection such as gas gangrenes and food borne toxin-
mediated infections. septic arthritis due to Clostridium per-
fringens is very rare. in the litterature 14 cases have been 
reported (5). the aetiology was post-traumatic for 7 of them, 
haematogenous for only 2 of them, and unknown or not 
reported for the last 5. the joint involved was the knee for half 
of them, and one case affected the hip. the treatment was 
arthrotomy and antibiotics (penicillin, cefotaxime or vanco-
mycine) in 10 of them. the treatment of choice is iv penicillin. 
Because the patient refused to stay hospitalised, we shifted 
to oral penicillin and clindamycin. oral clindamycin has been 
successfully used in bone infections, in mono- or bitherapy, 
although mostly in staphylococcus aureus infections (9-11). 
